Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma

13Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Gastroesophageal junction (GEJ) adenocarcinoma is a lethal cancer with rising incidence, yet the molecular biomarkers that have strong prognostic impact and also hold great therapeutic promise remain elusive. We used a data mining approach and identified the p21 protein-activated kinase 1 (PAK1), an oncogene and drugable protein kinase, to be among the most promising targets for GEJ adenocarcinoma. Immunoblot analysis and data mining demonstrated that PAK1 protein and mRNA were upregulated in cancer tissues compared to the noncancerous tissues. Immunohistochemistry revealed PAK1 overexpression in 72.6% of primary GEJ adenocarcinomas (n = 113). A step-wise increase in PAK1 levels was noted from paired normal epithelium, to atypical hyperplasia and adenocarcinoma. PAK1 overexpression in tumor was associated with lymph node (LN) metastasis (P<0.001), advanced tumor stage (P<0.001), large tumor size (P = 0.006), residual surgical margin (P = 0.033), and unfavorable overall survival (P<0.001). Multivariate analysis showed PAK1 overexpression is an independent high-risk prognostic predictor (P<0.001). Collectively, PAK1 is overexpressed during tumorigenic progression and its upregulation correlates with malignant properties mainly relevant to invasion and metastasis. PAK1 expression could serve as a prognostic predictor that holds therapeutic promise for GEJ adenocarcinoma. © 2013 Li et al.

References Powered by Scopus

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

17391Citations
N/AReaders
Get full text

Cluster analysis and display of genome-wide expression patterns

13610Citations
N/AReaders
Get full text

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial

6208Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling

240Citations
N/AReaders
Get full text

Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling

65Citations
N/AReaders
Get full text

PAKs in Human Cancer Progression. From Inception to Cancer Therapeutic to Future Oncobiology.

59Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, Z., Zou, X., Xie, L., Dong, H., Chen, Y., Liu, Q., … Zhang, H. (2013). Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma. PLoS ONE, 8(11). https://doi.org/10.1371/journal.pone.0080665

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

61%

Researcher 7

39%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

50%

Biochemistry, Genetics and Molecular Bi... 5

25%

Agricultural and Biological Sciences 4

20%

Computer Science 1

5%

Save time finding and organizing research with Mendeley

Sign up for free